The worst of both worlds: Zooming from the office
Many companies are finding it's difficult in the hybrid workplace, a mushy middle ground between remote and in-person work. At stake: the question of whether...
Demand surges for deworming drug for COVID, despite no evidence it works
Demand for ivermectin, a drug typically used to treat parasitic worms, has risen sharply in recent weeks, despite no evidence that it is effective against...
Breakthrough COVID cases: uncommon and often mild, but not always
Vaccination remains the best defense against COVID-19, health experts say. Breakthrough infections are relatively uncommon, and rarely result in severe illness or hospitalizations. But some...
Harvard’s new chief chaplain? An atheist.
Greg Epstein, author of the book “Good Without God,” will coordinate the activities of more than 40 university chaplains, who lead the Christian, Jewish, Hindu,...
Why thousands of doctors in America can’t get a job
Medical schools are producing more graduates, but residency programs haven’t kept up, leaving thousands of young doctors deep in debt and "chronically unmatched," a prospect...
The White House is taking women’s issues seriously. Really.
Amid a pandemic and an economic downturn that have devastated women professionally and personally, the Gender Policy Council will play a critical role in pushing...
For many, COVID-19 lingers for months, taxing mind as well as body
They call themselves "long-haulers," those whose COVID-19 cases have persisted for months. In addition to physical misery, they're experiencing mental-health stress. Science doesn't have answers...
‘Techlash’ hits college campuses
Facebook, Google and other major tech firms were every student’s dream workplaces. Until they weren’t.